ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

08 Sep 2022

Eco Animal Health - FY Results - Investor Presentation video - 7 September 2022

ECO Animal Health Group plc (AIM: EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, conducted an Investor Presentation on 7 September 2022 covering their Audited Results for the period ended 31 March.

David Hallas, CEO, and Christopher Wilks, CFO, provided a detailed overview of the operational and financial highlights of the period, discussed the outlook, updated investors on R&D and shared insights on pork pricing & China. The management team also answered questions from the viewing audience.

The full video recording is available below, divided into chapters for ease of viewing:
0:00:03 introduction & summary highlights
0:01:58 Financial highlights from results
0:24:43 Audit & Governance
0:30:27 Pork pricing & China
0:33:28 R&D update
0:39:44 Outlook
0:42:09 Questions & Answers

Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 2nd Floor, Park House, 16-18 Finsbury Circus, London, EC2M 7EB

Website design & development by Breckenridge